RECRUITING

Chinese American Cancer Survivors Writing Study

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.

Official Title

A Randomized Controlled Trial Testing Expressive Helping for Chinese American Cancer Survivors

Quick Facts

Study Start:2022-07-14
Study Completion:2025-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05456100

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Over 18 years old.
  2. * Prefer speaking in Mandarin Chinese or Cantonese, and able to read and write Simplified or Traditional Chinese.
  3. * Within 5 years after completing primary treatment or have completed primary treatment but still on medication for managing cancer-related symptoms.
  1. * Difficulties with writing
  2. * Current active participation in support groups (i.e., attending more than once per week)

Contacts and Locations

Study Contact

William Tsai, PhD
CONTACT
(212)998-5552
will.tsai@nyu.edu

Study Locations (Sites)

New York University
New York, New York, 10003
United States

Collaborators and Investigators

Sponsor: New York University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-14
Study Completion Date2025-07-31

Study Record Updates

Study Start Date2022-07-14
Study Completion Date2025-07-31

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer